Royce & Associates’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$677K Hold
12,255
0.01% 701
2025
Q1
$593K Buy
+12,255
New +$593K 0.01% 719